How does Industry 4.0 change pharmaceutical manufacturing? Transitioning to Pharma 4.0 offers both new opportunities and challenges.
This event provides an appropriate platform for industry professionals and technology leaders to discuss the best practices and experience of introducing, implementing and managing emerging technology capabilities.
The recall of Valsartan containing NDMA by several companies has highlighted the importance of a risk assessment strategy for potential nitrosamines in the pharmaceutical product.
Based on the critical issues and lessons learn from the sartans incidents, the appropriate control strategies to be established in order to prevent or minimize the presence of nitrosamine impurities, and to improve manufacturing processes.
Besides looking precisely on the N-Nitrosamines, exploring current investigations, regulatory expectations, and related impacts on implementation of ICH M7, at #VLgenotoxic we will continue discovering the advances around mutagenic impurities and extractables & leachables.
Join LIVE the interactive discussion, Q&A and networking sessions on the advanced strategies and perspectives in the respective field, and visit a virtual expo.
Addressing cellular and gene therapy-related developments and manufacturing controls, cell and gene therapies experts and advisers will exchange practical insights and expectations on:
The link between manufacturing and commercialization of gene and cell therapy is becoming more visible, since strategies are planned and implemented from the earliest stages of development.
7th HPAPI Online Summit is bringing a 2-day program of live talks, networking, personal communication, and Q&A sessions with selected speakers among the leading experts, both manufacturers and outsourcers.
Welcome to discuss: handling and security, cost-effective production, newest manufacturing innovations, regulatory updates, and emerging market trends for HPAPI!
Gene Therapies, CAR-T Cell Therapies, and other Advanced Therapy Medicinal Products (ATMPs) are advancing rapidly, demonstrating tremendous progress while developers continue struggling with CMC, analytical, process development, and manufacturing challenges.
At the Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit on November 18-19, 2021, topics that experts from the industry will discuss include:
Welcome to learn more about the current changes in the European regulations, emerging technologies and innovation in pharmaceutical manufacturing, aseptic fill and finish, quality control, engineering and container development, robotics in aseptic processing, gloveless isolators and dose control, commercial sterilization, and a lot more.
Eager to learn about the top trends and strategies in sports science, strength & conditioning, performance, and tactical analysis, talent identification, or scouting?
Join our two-days live session and discover the latest trends and developments in Football Analytics and Talent ID, focusing on the best practices in Data/Performance analysis as well as the best Talents’ development uncovering tools, strategies, and hints.
Vonlanthen Group of Companies is thrilled to be presenting the 9th Global Executive Assistant Hybrid Summit, this time as a hybrid event. Join our expert speakers from the comfort of your own home or from the conference room in magnificent Barcelona.
The volatility of the business world is bringing a lot of extra work and responsibilities to everyday life; how are you managing the stress? Do you enjoy working in that environment, or are you looking for tips that can help you find that ideal work/life balance?
Join us and meet new friends for an experience that will leave you inspired, informed, and empowered!
The year 2020 was a year of unprecedented change. The business landscape faced paramount disruptions and went through a significant evolution in workplace learning. Organizations from all around the world were pushed to employ the new standard of remote working as well as remote training considering the aspects of safety, well-being, and of course, team engagement.
Learning and Development (L&D) professionals have been required to quickly adapt and rethink the learning ecosystem support remote working and new business initiatives.
Industry 4.0 is transforming companies' operations from production efficiency to product customization through the power of:
The experts in the field will focus on the emerging tech, automation, and digitalization, achieved by Manufacturing 4.0, enriched by personalized human touch, and making a shift towards more collaborative operation at Industry 5.0.
COVID-19 has disrupted the innovation landscape. In order to grow in the "new normal" and to accelerate sustainable development progress, companies need to foster their research, innovation and collaboration efforts based on the longer-term science, tech and market shifts.
We will continue the innovation journey with the key experts in the area at #VLOpenInn on 18-19 November 2021!
By subscribing you have read and agreed to our Terms & Conditions and GDPR.
X Production s.r.o.